134 related articles for article (PubMed ID: 1728416)
41. Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.
Hirschel-Scholz S; Caverzasio J; Rizzoli R; Bonjour JP
J Clin Invest; 1986 Jul; 78(1):319-22. PubMed ID: 3013941
[TBL] [Abstract][Full Text] [Related]
42. Establishment of a parathyroid hormone-like factor-producing esophageal carcinoma cell line (EC-GI).
Sato K; Kasono K; Ohba Y; Yashiro T; Fujii Y; Yoshida MA; Tsushima T; Shizume K
Jpn J Cancer Res; 1987 Oct; 78(10):1044-8. PubMed ID: 2824416
[TBL] [Abstract][Full Text] [Related]
43. Production of interleukin-1 alpha and a parathyroid hormone-like factor by a squamous cell carcinoma of the esophagus (EC-GI) derived from a patient with hypercalcemia.
Sato K; Fujii Y; Kasono K; Tsushima T; Shizume K
J Clin Endocrinol Metab; 1988 Sep; 67(3):592-601. PubMed ID: 3261732
[TBL] [Abstract][Full Text] [Related]
44. Quantitative bone histomorphometry in nude mice bearing a human squamous cell lung cancer.
Kukreja SC; Rosol TJ; Shevrin DH; York PA
J Bone Miner Res; 1988 Jun; 3(3):341-6. PubMed ID: 3213626
[TBL] [Abstract][Full Text] [Related]
45. Ultrastructural and histomorphometric evaluations of gallium nitrate on bone in nude mice bearing a canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
Okada H; Merryman JI; Capen CC; Rosol TJ
Vet Pathol; 1995 Jan; 32(1):36-42. PubMed ID: 7725596
[TBL] [Abstract][Full Text] [Related]
46. Increased renal calcium reabsorption in an animal model of hypercalcemia of human malignancy.
Shipley PJ; Shevrin DH; Kukreja SC
J Bone Miner Res; 1988 Oct; 3(5):555-60. PubMed ID: 3195367
[TBL] [Abstract][Full Text] [Related]
47. Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo.
Uy HL; Guise TA; De La Mata J; Taylor SD; Story BM; Dallas MR; Boyce BF; Mundy GR; Roodman GD
Endocrinology; 1995 Aug; 136(8):3207-12. PubMed ID: 7628353
[TBL] [Abstract][Full Text] [Related]
48. Tumor necrosis factor alpha and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H]tetracycline excretion from prelabeled mice.
König A; Mühlbauer RC; Fleisch H
J Bone Miner Res; 1988 Dec; 3(6):621-7. PubMed ID: 3266953
[TBL] [Abstract][Full Text] [Related]
49. Tumor resection and antibodies to parathyroid hormone-related protein cause similar changes on bone histomorphometry in hypercalcemia of cancer.
Kukreja SC; Rosol TJ; Wimbiscus SA; Shevrin DH; Grill V; Barengolts EI; Martin TJ
Endocrinology; 1990 Jul; 127(1):305-10. PubMed ID: 2361475
[TBL] [Abstract][Full Text] [Related]
50. Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice.
Johnson RA; Boyce BF; Mundy GR; Roodman GD
Endocrinology; 1989 Mar; 124(3):1424-7. PubMed ID: 2917519
[TBL] [Abstract][Full Text] [Related]
51. [Hypocalcemic effect of elcatonin in mouse models for humoral hypercalcemia of malignancy].
Isogai Y; Hori M
Nihon Yakurigaku Zasshi; 1995 Apr; 105(4):199-208. PubMed ID: 7774857
[TBL] [Abstract][Full Text] [Related]
52. Hypercalcemia associated with infantile fibrosarcoma producing parathyroid hormone-related protein.
Michigami T; Yamato H; Mushiake S; Nakayama M; Yoneda A; Satomura K; Imura K; Ozono K
J Clin Endocrinol Metab; 1996 Mar; 81(3):1090-5. PubMed ID: 8772581
[TBL] [Abstract][Full Text] [Related]
53. Effects of humoral hypercalcemia of malignancy on the parathyroid gland in nude mice.
Gröne A; Rosol TJ; Baumgärtner W; Capen CC
Vet Pathol; 1992 Jul; 29(4):343-50. PubMed ID: 1514221
[TBL] [Abstract][Full Text] [Related]
54. Hypercalcemia and cosecretion of interleukin-6 and parathyroid hormone related peptide by a human renal cell carcinoma implanted into nude mice.
Weissglas M; Schamhart D; Löwik C; Papapoulos S; Vos P; Kurth KH
J Urol; 1995 Mar; 153(3 Pt 1):854-7. PubMed ID: 7861550
[TBL] [Abstract][Full Text] [Related]
55. Effects of humoral hypercalcemia of malignancy and gallium nitrate on thyroid C cells in nude mice: immunohistochemical and ultrastructural investigations.
Okada H; Merryman JI; Rosol TJ; Capen CC
Vet Pathol; 1994 May; 31(3):349-57. PubMed ID: 8053130
[TBL] [Abstract][Full Text] [Related]
56. The role of the calcitonin receptor in protecting against induced hypercalcemia is mediated via its actions in osteoclasts to inhibit bone resorption.
Turner AG; Tjahyono F; Chiu WS; Skinner J; Sawyer R; Moore AJ; Morris HA; Findlay DM; Zajac JD; Davey RA
Bone; 2011 Feb; 48(2):354-61. PubMed ID: 20850575
[TBL] [Abstract][Full Text] [Related]
57. Interleukin-4 blocks parathyroid hormone-related protein-induced hypercalcemia in vivo.
Nagasaki K; Yamaguchi K; Watanabe K; Eto S; Abe K
Biochem Biophys Res Commun; 1991 Jul; 178(2):694-8. PubMed ID: 1859425
[TBL] [Abstract][Full Text] [Related]
58. Changes in bone and bone marrow of rabbits bearing the VX-2 carcinoma. A comparison of local and distant effects.
Hough A; Seyberth H; Oates J; Hartmann W
Am J Pathol; 1977 Jun; 87(3):537-52. PubMed ID: 869013
[TBL] [Abstract][Full Text] [Related]
59. Ascites sarcoma 180, an animal model of humoral hypercalcemia of malignancy, produces a factor(s) exhibiting potent bone-resorbing activity without any parathyroid hormone-like activity.
Suzuki K; Yamada S
Bone Miner; 1991 Jul; 14(1):1-13. PubMed ID: 1651137
[TBL] [Abstract][Full Text] [Related]
60. Thionapthene-2-carboxylic acid: a new antihypercalcemic agent.
Johannesson AJ; Onkelinx C; Rodan GA; Raisz LG
Endocrinology; 1985 Oct; 117(4):1508-11. PubMed ID: 4029089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
